A Case of Immune Thrombocytopenic Purpura Developing after Treatment for Non-Hodgkin's Lymphoma.
10.5045/kjh.2009.44.2.113
- Author:
Hui Young LEE
1
;
Dae Joon JEONG
;
Dong Gyu LEE
;
Kwangjin CHUN
;
Sook Won RYU
;
Seo Young SONG
Author Information
1. Department of Internal Medicine, College of Medicine, Kangwon National University, Chuncheon, Korea. sysong@kangwon.ac.kr
- Publication Type:Case Report
- Keywords:
Idiopathic thrombocytopenic purpura;
Non-Hodgkin's lymphoma;
Splenectomy
- MeSH:
Hodgkin Disease;
Humans;
Lymphoma, Non-Hodgkin;
Lymphoproliferative Disorders;
Middle Aged;
Prevalence;
Purpura, Thrombocytopenic, Idiopathic;
Splenectomy;
Stem Cell Transplantation
- From:Korean Journal of Hematology
2009;44(2):113-116
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Immune thrombocytopenic purpura (ITP) can be classified as primary or secondary according to the presence of an underlying non-malignant or malignant disorder, including lymphoproliferative disorders. The estimated prevalence of ITP in patients with Hodgkin's lymphoma is about 1%, and its clinical course has been reported in approximately 50 patients. ITP is an unusual and poorly documented complication in patients with non-Hodgkin's lymphoma. Some cases have been described in patients who have undergone high-dose chemotherapy and autologous bone marrow/peripheral blood stem cell transplantation. Rare cases appear to be coincidental. Here, we report on a rare case of a 61-year-old man who had ITP after being in a state of complete remission of non-Hodgkin's lymphoma for about 15 months.
